Deep dive to free medical topics. Comprehensive and detailed essay. Personal thoughts.
It began as a £1 pandemic favour and grew into a £330 million contract. Between the two, Palantir became embedded in the plumbing of the NHS — and a question the health service still cannot answer cleanly took hold: did the platform actually work, and at what cost to trust?
Why do older adults end up on so many medications? Polypharmacy in older adults is less a prescribing failure than a byproduct of medical success — and the fix is a smarter system, not simply fewer pills.
A practicing ENT explains the medications that cause dizziness in older adults — and the ringing ears, hearing loss, nosebleeds, and dry mouth that often travel with them
The earbud feature everyone is discussing is live translation. The quieter capability beneath it — AI speech clarification, or making same-language speech intelligible for people who hear sound but miss words — matters more. The clinical evidence is encouraging and narrow: AI does not restore lost hearing, but it can make residual hearing more usable.
The AirPods hearing test accurately screens for hearing loss but cannot diagnose its cause. What the evidence shows it can and cannot do.
Antibiotics vs. antivirals: why one antibiotic treats many infections while antivirals stay narrow, costly, and few.
An AI-designed anti-TSLP antibody is in Phase 3 for asthma. Whether it can extend to nasal polyps (CRSwNP) depends on more than a shared mechanism.
Acetaminophen and NSAIDs are dispensed interchangeably, but they don’t share a mechanism, a toxicity profile, or the same duration of action. An evidence-led look at what combination buys, what it costs, and when each drug truly wears off.
Neuralink VOICE returned a single sentence to an ALS patient who had not spoken in four years. The reason that sentence was speech, rather than restored sight or hearing, reveals more about brain-computer interfaces than the headlines did.
A clinical deep dive into convolutional neural networks in medicine — landmark studies in dermatology, ophthalmology, and otolaryngology, and the gap between benchmark accuracy and clinical utility.
